COMPANY
Past trials only
Keywords: oncology Bladder Cancer Cell Transitional Non-Muscle Invasive Bladder Cancer Bladder Cancer Urinary Bladder Transitional Cell Carcinoma of the Bladder Urinary Bladder Neoplasms Urologic Neoplasms Urogenital Neoplasms Urinary Bladder Diseases Urologic Diseases TSD-001
Location: Menlo Park, CA · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1/Phase 2: Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT03081858 | Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer | Phase 1/Phase 2 | Completed | May 17, 2018 | Aug 27, 2020 (actual) |
